Similar articles

• A marker for predictions of HCC recurrence postresection?

  Blendis L, Wong F. Blendis L, et al. Gastroenterology. 2002 Dec;123(6):2152-3. doi: 10.1053/gast.2002.1232152. Gastroenterology. 2002. PMID: 12454875 No abstract available.
• Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.

  Reddy MS, Manas DM. Reddy MS, et al. Transplantation. 2007 Feb 15;83(3):367-8. doi: 10.1097/01.tp.0000250657.24081.47. Transplantation. 2007. PMID: 17297420 No abstract available.
• [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].

  Fan J, Xu Y. Fan J, et al. Zhonghua Wai Ke Za Zhi. 2008 Nov 1;46(21):1602-5. Zhonghua Wai Ke Za Zhi. 2008. PMID: 19094749 Review. Chinese. No abstract available.
• Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation.

  Lohmann R, Bechstein WO, Langrehr JM, Knoop M, Lobeck H, Keck H, Lemmems HP, Blumhardt G, Neuhaus P. Lohmann R, et al. Transplant Proc. 1995 Feb;27(1):1245-6. Transplant Proc. 1995. PMID: 7533376 Clinical Trial. No abstract available.
• Treatment of recurrent hepatocellular carcinoma after liver transplantation.

  Davis E, Wiesner R, Valdecasas J, Kita Y, Rossi M, Schwartz M. Davis E, et al. Liver Transpl. 2011 Oct;17 Suppl 2:S162-6. doi: 10.1002/lt.22361. Liver Transpl. 2011. PMID: 21688382 Review. No abstract available.